Laura Sampietro-Colom

1.9k total citations
78 papers, 1.1k citations indexed

About

Laura Sampietro-Colom is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura Sampietro-Colom has authored 78 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Economics and Econometrics, 27 papers in General Health Professions and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura Sampietro-Colom's work include Health Systems, Economic Evaluations, Quality of Life (45 papers), Pharmaceutical Economics and Policy (19 papers) and Healthcare cost, quality, practices (12 papers). Laura Sampietro-Colom is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (45 papers), Pharmaceutical Economics and Policy (19 papers) and Healthcare cost, quality, practices (12 papers). Laura Sampietro-Colom collaborates with scholars based in Spain, Italy and Netherlands. Laura Sampietro-Colom's co-authors include Mireia Espallargues, Alı́cia Granados, Maria-Dolors Estrada, Laura Del Rı́o, Javier Setoaín, Ma Lourdes del Río Solá, Wija Oortwijn, Chris Henshall, Andrés Pichón-Rivière and Federico Augustovski and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medical Internet Research.

In The Last Decade

Laura Sampietro-Colom

69 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Sampietro-Colom Spain 20 551 344 163 126 115 78 1.1k
Frits van Merode Netherlands 14 169 0.3× 189 0.5× 37 0.2× 213 1.7× 612 5.3× 61 2.3k
Mattias Neyt Belgium 19 343 0.6× 108 0.3× 24 0.1× 53 0.4× 278 2.4× 103 1.2k
Ruth Lopert Australia 18 605 1.1× 255 0.7× 34 0.2× 66 0.5× 88 0.8× 49 1.1k
Marco Barbieri United Kingdom 14 524 1.0× 247 0.7× 17 0.1× 69 0.5× 79 0.7× 34 1.1k
Andrew Rouse United Kingdom 14 144 0.3× 113 0.3× 52 0.3× 101 0.8× 166 1.4× 37 881
Ross Maclean United States 20 282 0.5× 255 0.7× 17 0.1× 66 0.5× 135 1.2× 38 1.6k
Min Hu China 13 365 0.7× 496 1.4× 16 0.1× 86 0.7× 111 1.0× 57 1.3k
Francis Ruiz United Kingdom 18 389 0.7× 191 0.6× 4 0.0× 149 1.2× 97 0.8× 57 919
Kim Rose Olsen Denmark 20 291 0.5× 292 0.8× 42 0.3× 148 1.2× 79 0.7× 84 1.4k
Sharron O’Neill Australia 15 41 0.1× 139 0.4× 34 0.2× 116 0.9× 81 0.7× 46 795

Countries citing papers authored by Laura Sampietro-Colom

Since Specialization
Citations

This map shows the geographic impact of Laura Sampietro-Colom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Sampietro-Colom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Sampietro-Colom more than expected).

Fields of papers citing papers by Laura Sampietro-Colom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Sampietro-Colom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Sampietro-Colom. The network helps show where Laura Sampietro-Colom may publish in the future.

Co-authorship network of co-authors of Laura Sampietro-Colom

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Sampietro-Colom. A scholar is included among the top collaborators of Laura Sampietro-Colom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Sampietro-Colom. Laura Sampietro-Colom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bidino, Rossella Di, et al.. (2025). The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey. International Journal of Technology Assessment in Health Care. 41(1). e19–e19.
2.
Refolo, Pietro, Josep M. Borràs, Alessandra Lo Scalzo, et al.. (2025). Policy Challenges in Ultra-Rare Cancers: Ethical, Social, and Legal Implications of Melanoma Prevention and Diagnosis in Children, Adolescents, and Young Adults. Healthcare. 13(3). 321–321. 3 indexed citations
3.
Refolo, Pietro, Josep M. Borràs, Alessandra Lo Scalzo, et al.. (2025). Ethical, Legal, and Social Assessment of AI-Based Technologies for Prevention and Diagnosis of Rare Diseases in Health Technology Assessment Processes. Healthcare. 13(7). 829–829.
4.
Rubio, Olga, et al.. (2025). Integrating Patient Perspectives Into the Digital Health Technology Readiness Framework: Delphi Study. Journal of Medical Internet Research. 27. e71600–e71600.
5.
Alarcón, Marcelo, et al.. (2024). HPR34 How Payment Schemes Drive the Adoption of Transcatheter Aortic Valve Implantation?. Value in Health. 27(12). S282–S282.
6.
Tarricone, Rosanna, Helen Banks, Oriana Ciani, et al.. (2023). An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations. Expert Review of Medical Devices. 20(4). 259–271. 8 indexed citations
7.
Sampietro-Colom, Laura, et al.. (2023). VALIDATE approach on medication adequacy clinical decision support systems: Holistic assessment for optimal technology adoption. Health Policy and Technology. 12(4). 100811–100811. 1 indexed citations
8.
Wilt, Gert Jan van der, John Grin, Iñaki Gutiérrez‐Ibarluzea, et al.. (2022). Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach. International Journal of Technology Assessment in Health Care. 38(1). e52–e52. 16 indexed citations
9.
Refolo, Pietro, John Grin, Iñaki Gutiérrez‐Ibarluzea, et al.. (2022). Prioritization of COVID-19 vaccination. The added value of the “VALIDATE” approach. Health Policy. 126(8). 770–776. 2 indexed citations
10.
Grin, John, Iñaki Gutiérrez‐Ibarluzea, Bjørn Hofmann, et al.. (2022). Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project. International Journal of Technology Assessment in Health Care. 38(1). e63–e63. 2 indexed citations
11.
Pichón-Rivière, Andrés, Federico Augustovski, Sebastián García Martí, et al.. (2021). Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America. International Journal of Technology Assessment in Health Care. 37(1). e80–e80. 3 indexed citations
12.
Tarricone, Rosanna, Oriana Ciani, Aleksandra Torbica, et al.. (2020). Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective. Expert Review of Medical Devices. 17(10). 993–1006. 24 indexed citations
13.
Pichón-Rivière, Andrés, Federico Augustovski, Sebastián García Martí, Verónica Alfie, & Laura Sampietro-Colom. (2020). The link between health technology assessment and decision making for the allocation of health resources in Latin America. International Journal of Technology Assessment in Health Care. 36(2). 173–178. 21 indexed citations
14.
Tummers, Marcia, Kari Jorunn Kværner, Laura Sampietro-Colom, et al.. (2020). On the integration of early health technology assessment in the innovation process: reflections from five stakeholders. International Journal of Technology Assessment in Health Care. 36(5). 481–485. 15 indexed citations
15.
Moroni, Luca, et al.. (2019). Economic Analysis of the Use of Anti-DFS70 Antibody Test in Patients with Undifferentiated Systemic Autoimmune Disease Symptoms. The Journal of Rheumatology. 47(8). 1275–1284. 8 indexed citations
16.
Pichón-Rivière, Andrés, Natalie Soto, Federico Augustovski, & Laura Sampietro-Colom. (2018). STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA. International Journal of Technology Assessment in Health Care. 34(3). 248–253. 13 indexed citations
17.
Pichón-Rivière, Andrés, Natalie Soto, Federico Augustovski, Sebastián García Martí, & Laura Sampietro-Colom. (2018). HEALTH TECHNOLOGY ASSESSMENT FOR DECISION MAKING IN LATIN AMERICA: GOOD PRACTICE PRINCIPLES. International Journal of Technology Assessment in Health Care. 34(3). 241–247. 21 indexed citations
18.
Sampietro-Colom, Laura, Iris Pasternack, Jean‐Blaise Wasserfallen, et al.. (2015). GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS. International Journal of Technology Assessment in Health Care. 31(6). 457–465. 38 indexed citations
19.
Sampietro-Colom, Laura, Mireia Espallargues, Mercè Comas, et al.. (2006). Priorización de pacientes en lista de espera para cirugía de cataratas: diferencias en las preferencias entre ciudadanos. Hispana. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026